- About us
- About Vaccines
- Media centre
- EU initiatives
Europe is at the heart of global vaccine research and production. Most of the activities of the major innovative Vaccines Europe members research based-companies are based in the region.
7th December 2018
Vaccines Europe welcomes the EU Council Recommendation on strengthened cooperation against vaccine-preventable diseases. Speaking about the Recommendation, Pascale Mauran, President of Vaccines Europe said “The Recommendation represents a major step towards addressing the different vaccines and vaccination-related challenges faced by the EU Member States such as increasing vaccination hesitancy, low vaccine uptake. Implementing the Recommendation will require stronger collaboration between all relevant stakeholders, in particular, national public health authorities and the European Commission. At Vaccines Europe we are looking forward to collaborating and supporting the implementation of the EU Council Recommendation in order to secure full protection of all EU citizens against vaccine-preventable diseases.”
Vaccination is one of the most powerful and cost-effective public health measures developed in the 20th century and remains the main tool for primary prevention of communicable diseases. Vaccination programs should go beyond childhood, taking a life-course approach to address epidemiological shifts in the burden of vaccine-preventable diseases. Moreover, vaccination can be an important instrument in addressing antimicrobial resistance.
Read the full Vaccines Europe statement here.
The six undersigned European health industry associations are ambitious about a healthier future for the European citizens, based on medical innovation, timely access to quality health interventions, better health outcomes for patients, and affordable healthcare. Horizon Europe has a key role to play in that future.
Vaccines Europe recognises the enormous and decade-long commitment of the European Centre for Disease Prevention and Control and the European Commission to raising awareness about the global problem of antimicrobial resistance (AMR), in the European population. This major public health threat has made the EU and other countries worldwide take certain steps in order to protect their citizens from dangerous bacteria. Read our full statement here.
Europe is a long-standing leader in vaccines. Maintaining this position and ensuring vaccine availability in times of increased demand and supply constraints can only be achieved by a committed industry, operating in a stable environment, able to produce vaccines of the highest quality and to innovate to meet future vaccine needs.
Shortages of medicines, including vaccines, are of increasing concern in the EU and globally. The causes are multiple. Finding solutions requires a concerted effort by all key stakeholders. Vaccines Europe is contributing to finding such solutions.
We describe the potential labelling/packaging improvements that could facilitate vaccine supply in our position paper accessible here.